Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: January 30, 2018

Monepantel reformulation successfully increases dose and improves taste

News & Announcements 2018By Richard Hopkins January 30, 2018

BRI update_clean

Recent Articles

200921_PharmAust Awarded FightMND Grant for Phase I Trial
September 21, 2020
14 September, Shareholder Update
September 14, 2020
Elanco not to Exercise Agreed Option
September 9, 2020
Monepantel Anti-Covid-19 Activity Confirmed
September 9, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

PharmAust receives grant from FightMND for monepantel phase one trial in motor neuron disease https://smallcaps.com.au/pharmaust-fightmnd-monepantel-phase-one-trial-motor-neuron-disease/ via @SmallCapsASX

Reply on Twitter 1307832264269598720 Retweet on Twitter 1307832264269598720 Like on Twitter 13078322642695987203 Twitter 1307832264269598720

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions